TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29141087

Group type: EXPERIMENTAL
Intervention: Supervised exercise + GM-CSF (n=53)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: GM-CSF alone (n=53)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Supervised exercise alone (n=53)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Attention control + placebo (n=51)
Number of subjects: 210
Study: 26774378

Group type: EXPERIMENTAL
Intervention: Educator-led gross motor skill and physical activity program
Number of subjects: 150

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 150
Study: 23752040

Group type: EXPERIMENTAL
Intervention: Polarized endurance-training distribution (PET)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Moderately high-intensity (between-thresholds) endurance-training program (BThET)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Subset analysis of PET (n = 6)
Number of subjects: 30
Study: 22791118

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS), treated once daily for 4 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo, treated once daily for 4 weeks.
Number of subjects: 0
Study: 19517902

Group type: EXPERIMENTAL
Intervention: Reports of RCTs
Number of subjects: 54
Study: 17563998

Group type: EXPERIMENTAL
Intervention: Konsol
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Konsol MF
Number of subjects: 100

Group type: COMPARATOR
Intervention: St. Thomas
Number of subjects: 100
Study: 15361093

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection followed by graded pneumatic dilatation (PD) with 30 mm balloons
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group treated only with graded pneumatic dilatation (PD)
Number of subjects: 12
Study: 11848530

Group type: EXPERIMENTAL
Intervention: Total androgen ablation before RP
Number of subjects: 192

Group type: COMPARATOR
Intervention: No total androgen ablation before RP
Number of subjects: 192
Study: 9595980

Group type: EXPERIMENTAL
Intervention: 11C-methionine PET
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 196

Group type: COMPARATOR
Intervention: Threshold differentiation
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Recurrent or residual tumors
Number of subjects: 196
Study: 7947417

Group type: EXPERIMENTAL
Intervention: Haloperidol treatment (on medication)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Drug-free baseline (off medication)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Stable schizophrenic outpatients (n = 12)
Number of subjects: 13
Study: 2976414

Group type: EXPERIMENTAL
Intervention: Short-acting GnRH agonist (100-500 micrograms daily)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Long-acting GnRH agonist (3.2 mg bolus)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Patients with elevated LH/FSH ratio
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Combined GnRH-agonist/gonadotrophin stimulation
Number of subjects: 119
Study: 29450895

Group type: EXPERIMENTAL
Intervention: Automatic action tendency retraining
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control condition (sham training)
Number of subjects: 72
Study: 27424879

Group type: EXPERIMENTAL
Intervention: Direct extraction of third molars with acute pulpitis (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Endodontic therapy followed by extraction (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Direct extraction of third molars without acute pulpitis (Group C)
Number of subjects: 60
Study: 24986722

Group type: EXPERIMENTAL
Intervention: TNT at 608 kPa (6 atm abs)
Number of subjects: 139

Group type: COMPARATOR
Intervention: TNT at 101.3 kPa (normal conditions)
Number of subjects: 139
Study: 22672237

Group type: EXPERIMENTAL
Intervention: 0.15 mol L(‐1) HCl infusion
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 25
Study: 20379739

Group type: EXPERIMENTAL
Intervention: Appendicitis-score-group (n = 96)
Number of subjects: 177

Group type: COMPARATOR
Intervention: No-score-group (n = 81)
Number of subjects: 177
Study: 18573823

Group type: EXPERIMENTAL
Intervention: Atorvastatin as add-on therapy to interferon-beta 1b
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon-beta 1b
Number of subjects: 0
Study: 16085593

Group type: EXPERIMENTAL
Intervention: mu-opioid receptor binding in bulimic subjects
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (female controls)
Number of subjects: 16
Study: 12451158

Group type: EXPERIMENTAL
Intervention: Perceived social support
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Burden
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Self-esteem
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Hours of informal care
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Behavioral problems
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Frequency of getting a break
Number of subjects: 243
Study: 11561574

Group type: EXPERIMENTAL
Intervention: Isepamicin
Number of subjects: 41

Group type: COMPARATOR
Intervention: Amikacin
Number of subjects: 41
Study: 8983446

Group type: EXPERIMENTAL
Intervention: Serum IL-4 concentration (0.06 ng/ml)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Serum GM-CSF concentration (4.4 pg/ml)
Number of subjects: 35
Study: 8195848

Group type: EXPERIMENTAL
Intervention: Brodimoprim (single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Co-trimoxazole (trimethoprim 160 mg + sulphamethoxazole 800 mg every 12 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Erythromycin (600 mg three times a day)
Number of subjects: 0
Study: 3763654

Group type: EXPERIMENTAL
Intervention: 2% fusidic acid plus 0.1% betamethasone cream
Number of subjects: 99

Group type: COMPARATOR
Intervention: 0.1% gentamicin plus 0.1% betamethasone cream
Number of subjects: 99
Study: 29696360

Group type: EXPERIMENTAL
Intervention: Cisplatin and gemcitabine with folic acid and vitamin B12 supplementation
Number of subjects: 82

Group type: COMPARATOR
Intervention: Cisplatin and gemcitabine without folic acid and vitamin B12 supplementation (control)
Number of subjects: 82
Study: 27583311

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 336

Group type: COMPARATOR
Intervention: Enoxaparin/VKA
Number of subjects: 336
Study: 25924781

Group type: EXPERIMENTAL
Intervention: CPAP (PEEP: 5 cm H2O, flow: 15 L/min, FiO2: 33 %) three times per week during hemodialysis sessions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 22177779

Group type: EXPERIMENTAL
Intervention: Selective endoscopic treatment of non-refluxing contralateral ureters (NRCU) in patients deemed at high risk (H2 or H3)
Number of subjects: 339

Group type: COMPARATOR
Intervention: Observation of non-refluxing contralateral ureters (NRCU) without treatment
Number of subjects: 339
Study: 21400196

Group type: EXPERIMENTAL
Intervention: 20,000 IU vitamin D(3) weekly and 500 mg calcium daily for 96 weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo and 500 mg calcium daily for 96 weeks
Number of subjects: 71
Study: 18339525

Group type: EXPERIMENTAL
Intervention: Pentoxifylline for 6 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard measures
Number of subjects: 40
Study: 16469753

Group type: COMPARATOR
Intervention: CVD regimen (cisplatin 30 mg/m2 on days 1-3, vindesine 2.5 mg/m2 on day 1, dacarbazine 250 mg/m2 on days 1-3)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: CVD regimen plus interferon-alpha2b (days 1-5) and interleukin-2 (days 1-5 and 8-15)
Number of subjects: 151
Study: 12906896

Group type: EXPERIMENTAL
Intervention: (R)-MDE
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: (S)-MDE
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: HME and MDA metabolites
Number of subjects: 4
Study: 11146955

Group type: EXPERIMENTAL
Intervention: Continuous in‐line blood gas management (CILBGM)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Intermittent sampling (control group)
Number of subjects: 59
Study: 7484483

Group type: EXPERIMENTAL
Intervention: Immediate conservative management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed conservative management
Number of subjects: 0
Study: 2250128

Group type: EXPERIMENTAL
Intervention: COMPAS (computer-based patient advice system)
Number of subjects: 5
Study: 7016150

Group type: EXPERIMENTAL
Intervention: Alprenolol (5-10 mg intravenously followed by 200 mg orally twice a day for one year)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo (5-10 mg intravenously followed by placebo orally twice a day for one year)
Number of subjects: 282
Study: 30676617

Group type: EXPERIMENTAL
Intervention: Ranibizumab (0.5 mg)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Aflibercept (2.0 mg)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Ranibizumab and Aflibercept
Number of subjects: 281
Study: 28274562

Group type: EXPERIMENTAL
Intervention: Preoperative biopsy
Number of subjects: 637

Group type: COMPARATOR
Intervention: Nonrandomized patients (no intervention)
Number of subjects: 637
Study: 26048069

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) therapy with lidocaine and bupivacaine
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (sterile 0.9% saline)
Number of subjects: 37
Study: 23835559

Group type: EXPERIMENTAL
Intervention: Modern knee implant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional knee implant
Number of subjects: 0
Study: 21451348

Group type: EXPERIMENTAL
Intervention: MOTR (motive-oriented therapeutic relationship)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Manual-based investigation process
Number of subjects: 25
Study: 19454394

Group type: EXPERIMENTAL
Intervention: Twice-daily insulin lispro mix 75/25 plus metformin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three times daily insulin lispro mix 50/50 plus metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine plus metformin
Number of subjects: 0
Study: 16725261

Group type: EXPERIMENTAL
Intervention: Opioid blockade (8mg naloxone i.v.)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo blockade (saline)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Finger pressure pain task
Number of subjects: 119
Study: 15531001

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10-40 mg
Number of subjects: 2268

Group type: COMPARATOR
Intervention: Atorvastatin (milligram-equivalent doses)
Number of subjects: 2268

Group type: COMPARATOR
Intervention: Simvastatin (milligram-equivalent or higher doses)
Number of subjects: 2268

Group type: COMPARATOR
Intervention: Pravastatin (milligram-equivalent or higher doses)
Number of subjects: 2268

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg
Number of subjects: 2268
Study: 11234973

Group type: EXPERIMENTAL
Intervention: Fluid restriction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maintenance therapy
Number of subjects: 0
Study: 9028341

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU) treatment
Number of subjects: 150
Study: 7930199

Group type: EXPERIMENTAL
Intervention: Distal coil as the anode
Number of subjects: 20

Group type: COMPARATOR
Intervention: Distal coil as the cathode
Number of subjects: 20
Study: 3284726

Group type: EXPERIMENTAL
Intervention: Neostigmine, 0.5 mg, administered intramuscularly every third hour on the third day after laparotomy, until passage of flatus or stools or a total of three injections
Number of subjects: 90

Group type: COMPARATOR
Intervention: Untreated patients (control group)
Number of subjects: 90
Study: 31241854

Group type: EXPERIMENTAL
Intervention: Intradermal PRP alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combined treatment with subcision followed by PRP injection
Number of subjects: 30
Study: 30802941

Group type: EXPERIMENTAL
Intervention: Emyna (eCBT intervention)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 200
Study: 28087552

Group type: EXPERIMENTAL
Intervention: AliveCor
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: WatchBP
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Polar H7 heart rate monitor
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Firstbeat Bodyguard 2
Number of subjects: 421

Group type: COMPARATOR
Intervention: 12-lead ECG
Number of subjects: 421
Study: 25497264

Group type: EXPERIMENTAL
Intervention: Insulin treatment in diabetic patients
Number of subjects: 3014

Group type: COMPARATOR
Intervention: Non-insulin treatment in diabetic patients
Number of subjects: 3014

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 3014

Group type: COMPARATOR
Intervention: Non-diabetic patients
Number of subjects: 3014
Study: 24432627

Group type: EXPERIMENTAL
Intervention: Yiqi Zhujing Granule (1 packet, bid) for 3 months
Number of subjects: 78

Group type: COMPARATOR
Intervention: Zinc gluconate liquid (10 ml, bid) and vitamin E (100 mg, bid) for 3 months (Control)
Number of subjects: 78
Study: 21354628

Group type: EXPERIMENTAL
Intervention: Exposed hospital personnel during the Gaza War
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Exposed hospital personnel 6 months later
Number of subjects: 268

Group type: COMPARATOR
Intervention: Unexposed hospital personnel
Number of subjects: 268
Study: 18156535

Group type: EXPERIMENTAL
Intervention: 8 mg oral dexamethasone
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 16925730

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Stavudine (d4T)
Number of subjects: 600
Study: 12881374

Group type: EXPERIMENTAL
Intervention: Mammographic screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Case-control studies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomised trials
Number of subjects: 0
Study: 10989897

Group type: EXPERIMENTAL
Intervention: Continuous fascial closure
Number of subjects: 331

Group type: COMPARATOR
Intervention: Interrupted fascial closure
Number of subjects: 331
Study: 8833622

Group type: EXPERIMENTAL
Intervention: Low-fat, high-carbohydrate diet
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 216

Group type: COMPARATOR
Intervention: Pilot studies participants
Number of subjects: 216
Study: 1483439

Group type: EXPERIMENTAL
Intervention: 6% CHO
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 12% CHO
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (water)
Number of subjects: 8
Study: 2931831

Group type: EXPERIMENTAL
Intervention: Baclofen (30-80 mg daily)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 31283822

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine supplementation (6-month duration)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (6-month duration)
Number of subjects: 9
Study: 29982704

Group type: EXPERIMENTAL
Intervention: Refined carbohydrate-enriched diet
Number of subjects: 11

Group type: COMPARATOR
Intervention: Simple carbohydrate-enriched diet
Number of subjects: 11

Group type: COMPARATOR
Intervention: Unrefined carbohydrate-enriched diet
Number of subjects: 11
Study: 27881108

Group type: EXPERIMENTAL
Intervention: Blended smoking cessation treatment (5 online sessions, 5 face-to-face sessions)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Face-to-face smoking cessation treatment (10 face-to-face sessions)
Number of subjects: 344
Study: 24549163

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of autologous bone marrow mononuclear cells (BMCs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 100
Study: 22676495

Group type: EXPERIMENTAL
Intervention: Patellar resurfacing (Resurfaced group)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Patellar retention (Non-resurfaced group)
Number of subjects: 38
Study: 20925951

Group type: EXPERIMENTAL
Intervention: Carbon ion radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fractionated stereotactic radiotherapy (FSRT) with a total dose of 36 Gy in single doses of 2 Gy
Number of subjects: 0
Study: 16996154

Group type: EXPERIMENTAL
Intervention: Oligofructose (OF) supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16327491

Group type: EXPERIMENTAL
Intervention: Clamp crushing technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: CUSA
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hydrojet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dissecting sealer
Number of subjects: 100
Study: 12072875

Group type: COMPARATOR
Intervention: Nonlitigious questionnaire
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Litigious questionnaire
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Parental litigiousness influence
Number of subjects: 1000
Study: 9469496

Group type: EXPERIMENTAL
Intervention: Calcium ketoglutarate
Number of subjects: 19

Group type: COMPARATOR
Intervention: Calcium carbonate
Number of subjects: 19
Study: 7703872

Group type: EXPERIMENTAL
Intervention: Accu‐Easy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Glucometer Encore
Number of subjects: 101

Group type: COMPARATOR
Intervention: Both monitors
Number of subjects: 101
Study: 2710173

Group type: EXPERIMENTAL
Intervention: Calcium acetate (4.4 g, 25 mmol of calcium)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 1102394

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30924600

Group type: EXPERIMENTAL
Intervention: Collagen matrix implant (Ologen®; OLO)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Mitomycin C (MMC)
Number of subjects: 45
Study: 27889320

Group type: EXPERIMENTAL
Intervention: Two intraoperative, intravenous doses (IOIO)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Two intraoperative local applications (LALA)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: One preoperative plus two intraoperative, intravenous doses (POIOIO)
Number of subjects: 75
Study: 26459326

Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) providing maternal and newborn health education through home visits and community engagement.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Early community engagement and supportive supervision of CHWs.
Number of subjects: 40
Study: 23025424

Group type: EXPERIMENTAL
Intervention: Use of the dosing aid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of the dosing aid with the drop guider
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of the dosing aid together with patient education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of the dosing aid and drop guider together with patient education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 21736730

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Brief Intervention plus Cognitive Behavioral Treatment (CBT)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Brief Intervention plus nutritional supplements of seal oil
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Brief Intervention plus nutritional supplements of soy oil
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 400
Study: 19772447

Group type: EXPERIMENTAL
Intervention: AIR inhaled insulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subcutaneous insulin (SC)
Number of subjects: 0
Study: 17294445

Group type: EXPERIMENTAL
Intervention: LHT+IT-DC (intratumoral injection of autologous immature dendritic cells after local hyperthermia)
Number of subjects: 18

Group type: COMPARATOR
Intervention: IT-DC (intratumoral injection of autologous immature dendritic cells without local hyperthermia)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: LHT+IT-DC
Number of subjects: 18

Group type: COMPARATOR
Intervention: IT-DC
Number of subjects: 18
Study: 15266633

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with 860 nm gallium/aluminum/arsenide laser at a dosage of 6 J/cm2, treated three times per week for 5 weeks.
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham laser treatment, treated three times per week for 5 weeks.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both groups (LLLT and sham)
Number of subjects: 15
Study: 11158191

Group type: EXPERIMENTAL
Intervention: Orchiectomy with flutamide
Number of subjects: 1263

Group type: COMPARATOR
Intervention: Orchiectomy without flutamide
Number of subjects: 1263
Study: 9358196

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8203201

Group type: EXPERIMENTAL
Intervention: Penicillin V (pcV) given intermittently upon signs of upper respiratory tract infections (URTI)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 3673877

Group type: EXPERIMENTAL
Intervention: Initial ST segment depression
Number of subjects: 304

Group type: COMPARATOR
Intervention: Initial ST segment elevation
Number of subjects: 304
Study: 29661497

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy with irinotecan (CPT‐11; 60 mg/m2 intravenously on days 1 and 8) and nedaplatin (NDP; 80 mg/m2 intravenously on day 1), administered within 6 weeks after surgery and repeated every 28 days for up to 5 cycles.
Number of subjects: 62
Study: 26655923

Group type: EXPERIMENTAL
Intervention: Shower group
Number of subjects: 444

Group type: COMPARATOR
Intervention: Nonshower group
Number of subjects: 444
Study: 24846652

Group type: EXPERIMENTAL
Intervention: AMG 157 (700 mg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 22119261

Group type: COMPARATOR
Intervention: Closure of the donor site
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nonclosure of the donor site
Number of subjects: 50
Study: 20195023

Group type: EXPERIMENTAL
Intervention: Cervical thrust manipulations
Number of subjects: 47

Group type: COMPARATOR
Intervention: Cervical nonthrust mobilizations
Number of subjects: 47
Study: 20183666

Group type: EXPERIMENTAL
Intervention: Service use by depressed adolescents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contact with a behavioral health specialist
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment-related costs
Number of subjects: 0
Study: 15662232

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg/day)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Grape-seed polyphenols (1000 mg/day)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Combination of vitamin C and grape-seed polyphenols
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo (neither intervention)
Number of subjects: 69